1202 SEQUENCE ANALYSIS OF HCV VARIANTS FROM A PHASE IIA TRIAL OF MIRAVIRSEN (MIR), AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT NAIVE PATIENTS WITH CHRONIC HCV INFECTION

✍ Scribed by Patick, A.K.; Chen, A.; van Doorn, L.J.; van der Veer, E.; Zeh, K.; Raney, A.K.; Hodges, M.R.

• Book ID: 123219296
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 67 KB
• Volume: 56
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(12)61214-8